In this webinar, Dr Gabriela Kramer-Marek, Team Leader in Preclinical Molecular Imaging The Institute of Cancer Research London, will focus on HER-specific imaging radioconjugates that could provide unique information as cancer biomarkers.

In this work, a new fluorescence probe, PQI, was developed for monitoring of the HOCl level in biological samples. The fluorescence of PQI was found to be significantly increased, leading to “OFF‐ON” fluorescence response towards HOCl.

Non-invasive in vivo phenotyping of adipose tissue deposits in small animal models is of great importance in preclinical metabolic research. In MRI, fat suppression is often performed to avoid artifacts arising from fat.

13C-Hyperpolarized molecules provide a unique signature for molecular processes relevant to a range of disease processes that can be imaged by MRI and promises improved detections for certain indications relative to traditional molecular imaging

The CellRad system allows you to irradiate cells in your lab without compromising sterility or security. A smaller, simpler, safer and less costly alternative to radioisotope and high-power x-ray irradiators.

Pancreatic ductal adenocarcinoma has been increasing by 0.5% per year in the United States. This study describes the generation and characterization of a novel oncolytic chimeric orthopoxvirus for the treatment of pancreatic cancer.

The ROI shrink‐wrap gives the possibility to automatically generate a region‐of‐interest by adapting to the shape of selected objects and the primitive ROI create an image for the region of interest containing a certain edge as binary object.